3rd annual Blood Cancer In America

Where Do I Go From Here? Decision Making After a Blood Cancer Diagnosis

After diagnosis, people with blood cancer are faced with many questions and difficult decisions. Is my diagnosis correct? Which treatment should I choose? Is my doctor the right one for me? As life turns upside down, it’s not uncommon to simply wonder, “Where do I go from here?”

We conducted a large survey to better understand people’s experiences with blood cancer. Over 1,900 people with blood cancer completed the survey, giving us a look at how they make decisions and learn about blood cancer from diagnosis through treatment and survivorship.

The role of second opinions

Second opinions can be a helpful way to confirm a diagnosis, figure out a treatment plan, and even find a doctor that better fits your needs. In total, 45% of people who took our survey received a second opinion. Around diagnosis was the most common time that respondents got a second opinion. Talking to another healthcare provider can help you to feel more confident about your decisions or even reveal new treatment opportunities or clinical trials.

Survey respondents received second opinions at diagnosis (22%), when selecting first treatment (9%), during treatment (7%), when changing treatments (5%), after recurrence (2%)

Staying up to date with blood cancer news and research

Blogs! Websites! Facebook! Support groups! There are many ways to learn about blood cancer and keep up with the latest research. 8 in 10 respondents use their doctor to learn about how to manage their blood cancer. Digital resources, including websites, Facebook, and online communities, have also become popular for staying up to date about blood cancer.

Ways people with blood cancer stay informed: Doctor of healthcare professional (80%), blood cancer-specific websites (68%), Facebook (32%), online support groups and communities (32%), patient blogs (28%)

Deciding on a treatment plan

Some common treatments for blood cancer include chemotherapy, targeted therapy, immunotherapy, watchful waiting, and stem cell transplant. The top 3 treatments first received were chemotherapy (46% of respondents), targeted therapy (25%), and watchful waiting (20%).

When faced with these treatment decisions, people with blood cancer will often take many factors into consideration. Nearly half of all respondents said that how well the treatment works was the most important factor in their decision to begin a treatment. Almost 1 in 4 selected a treatment because it was the only one available to them.

Top factors when deciding on treatment: Effectiveness, only treatment available, potential side effects, insurance coverage, location of treatment

Learning from others with blood cancer

Not everyone gets what it’s really like to live with or in remission from blood cancer. Nearly half of all respondents feel that others don’t understand what they are going through with their blood cancer and almost a third of respondents said they feel like a burden when sharing concerns or feelings with others.

Sometimes, the best way to learn about blood cancer and find support is by connecting with others who have been through it themselves. From in-person support groups to online communities to patient blogs, there are many ways to connect with blood cancer patients and caregivers.

24% of respondents learn about blood cancer from other patients and 26% have read patients’ opinions of medications online in the last 6 months

Staying informed as a survivor

Even though treatment may end, life after cancer can feel anything but normal. Some may feel pangs of worry about relapse or scanxiety before upcoming tests. Some may deal with long term side effects. Some must reacclimate to the workplace. Some may suddenly feel like they no longer fit in the world they once knew. There is no shortage of things to think about related to both physical and emotional health.

Keeping track of maintenance medications and follow up care -- from scans to blood tests and biopsies to routine doctor’s visits -- can be time-consuming and stressful. A survivorship care plan can make it easier to keep track of necessary follow up care and often provides a full description of your diagnosis, treatment(s), and healthcare team.

43% of respondents are in remission and 4 in 10 of those in remission have a survivorship care plan

The 3rd Annual Blood Cancer In America survey was conducted online from September of 2019 through February of 2020. Of the 1,919 people who completed the survey, 571 were people who have been diagnosed with multiple myeloma, 509 were people who have been diagnosed with lymphoma, 528 were people who have been diagnosed with leukemia, 196 were people who have been diagnosed with MPN, and 115 were people who have been diagnosed with MDS or another blood cancer.

By providing your email address, you are agreeing to our privacy policy.

More on this topic

Join the conversation

or create an account to comment.

Community Poll

Have you used CAR T therapy as a treatment for blood cancer?